9-Bromo-8-methoxythieno[2,3-c]quinolin-4(5H)-one, 97%, 250mg

N-(5-(p-Tolyl)-1,3,4-thiadiazol-2-yl)benzamide, 95%, 25mg

4-(1,3-Benzothiazol-2-yl)aniline, 97.0%, 1g

(S)-2-(2-((tert-Butoxycarbonyl)amino)-3-(1-trityl-1H-imidazol-4-yl)propanamido)-2-methylpropanoic acid, 97%, 5g

(R)-methyl 5-((S)-1,1-dimethylethylsulfinamido)-5-(4-morpholinophenyl)-3-oxo-5-(thiophen-3-yl)pentanoate, 97%, 100mg

6-Morpholin-4-ylpyridin-3-amine, 97.0%, 1g

4-Acetamidophenyl acetate, 98.0%, 100g

Methyl 6-(aminomethyl)nicotinate hydrochloride, 95.0%, 1g

6-Methyl-1H-indazol-5-ol, 95.0%, 1g

3,3-Difluorohexanoic acid ethyl ester (stabilised over Potassium Carbonate), 1g

N-(4-Bromo-3,5-difluorophenyl)acetamide, 95.0%, 100g

4-Chloro-5-methylquinazoline, 95.0%, 5g

Heptafluorobutyramide, 97.0%, 5g